Abstract
Purpose
This study examines the role of cell survival/apoptosis related proteins involved in NFκB signaling pathways and its associated events in GTP-induced chemoprevention of prostate cancer in TRAMP mice.
Methods
Mice were given 0.1% GTP as drinking fluid. Western blot and immunohistochemical analysis performed to examine NFκB and its regulated pathway in response to GTP.
Results
Our data demonstrated increased expression of NFκB, IKKα, IKKβ, RANK, NIK and STAT-3 in dorso-lateral prostate of TRAMP mice as a function of age and tumor growth and continuous GTP infusion for 32 weeks resulted in substantial reduction in these proteins. The levels of transcription factor osteopontin, a non-collagenous extracellular matrix protein, were also downregulated. Inhibition of NFκB signaling is known to activate apoptotic and inhibit anti-apoptotic proteins. Therefore, we analyzed Bax and Bcl2 levels in the dorsolateral prostate of TRAMP mice fed GTP and observed a shift in balance between Bax and Bcl2 favoring apoptosis.
Conclusions
Based on the data we suggest that oral consumption of GTP might inhibit osteopontin and NFκB signaling that may contribute to induction of apoptosis observed in GTP fed TRAMP mice.
Similar content being viewed by others
References
J. D. Albano, E. Ward, A. Jemal, R. Anderson, V. E. Cokkinides, T. Murray, J. Henley, J. Liff, and M. J. Thun. Cancer mortality in the United States by education level and race. J. Natl. Cancer Inst. 99:1384–1394 (2007).
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M. J. Thun. Cancer statistics, 2007. CA. Cancer J. Clin. 57:43–66 (2007).
A. W. Hsing, L. Tsao, and S. S. Devesa. International trends and patterns of prostate cancer incidence and mortality. Int. J. Cancer 85:60–67 (2000).
M. Quinn and P. Babb. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int. 90:162–173 (2002).
H. G. Sim and C. W. Cheng. Changing demography of prostate cancer in Asia. Eur. J. Cancer 41:834–845 (2005).
D. N. Syed, N. Khan, F. Afaq, and H. Mukhtar. Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol. Biomarkers Prev. 16:2193–2203 (2007).
I. A. Siddiqui, M. Saleem, V. M. Adhami, M. Asim, and H. Mukhtar. Tea beverage in chemoprevention and chemotherapy of prostate cancer. Acta. Pharmacol. Sin. 28:1392–1408 (2007).
E. D. Canby-Hagino and I. M. Thompson. Mechanisms of disease: prostate cancer—a model for cancer chemoprevention in clinical practice. Nat. Clin. Pract. Oncol. 2:255–261 (2005).
I. A. Siddiqui, F. Afaq, V. M. Adhami, and H. Mukhtar. Prevention of prostate cancer through custom tailoring of chemopreventive regimen. Chem. Biol. Interact. 171:122–132 (2008).
S. Bettuzzi, M. Brausi, F. Rizzi, G. Castagnetti, G. Peracchia, and A. Corti. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 66:1234–1240 (2006).
M. G. Neill and N. E. Fleshner. An update on chemoprevention strategies in prostate cancer for 2006. Curr. Opin. Urol. 16:132–137 (2006).
V. M. Adhami, I. A. Siddiqui, N. Ahmad, S. Gupta, and H. Mukhtar. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res. 64:8715–8722 (2004).
W. Liu, Y. Liu, and W. L. Lowe Jr. The role of phosphatidylinositol 3-kinase and the mitogen-activated protein kinases in insulin-like growth factor-I-mediated effects in vascular endothelial cells. Endocrinology 142:1710–1719 (2001).
F. Garrouste, M. Remacle-Bonnet, C. Fauriat, J. Marvaldi, J. Luis, and G. Pommier. Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism. Cell Death Differ. 9:768–779 (2002).
N. M. Greenberg, F. DeMayo, M. J. Finegold, D. Medina, W. D. Tilley, J. O. Aspinall, G. R. Cunha, A. A. Donjacour, R. J. Matusik, and J. M. Rosen. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. U S A 92:3439–3443 (1995).
S. Gupta, K. Hastak, N. Ahmad, J. S. Lewin, and H. Mukhtar. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. U S A 98:10350–10355 (2001).
I. A. Siddiqui, N. Zaman, M. H. Aziz, S. R. Reagan-Shaw, S. Sarfaraz, V. M. Adhami, N. Ahmad, S. Raisuddin, and H. Mukhtar. Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas. Carcinogenesis. 27:833–839 (2006).
A. C. Bharti, Y. Takada, S. Shishodia, and B. B. Aggarwal. Evidence that receptor activator of nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism. J. Biol. Chem. 279:6065–6076 (2004).
S. S. Forootan, C. S. Foster, V. R. Aachi, J. Adamson, P. H. Smith, K. Lin, and Y. Ke. Prognostic significance of osteopontin expression in human prostate cancer. Int. J. Cancer 118:2255–2261 (2006).
B. E. Barton, J. G. Karras, T. F. Murphy, A. Barton, and H. F. Huang. Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: direct STAT3 inhibition induces apoptosis in prostate cancer lines. Mol. Cancer Ther. 3:11–20 (2004).
M. H. Aziz, H. T. Manoharan, D. R. Church, N. E. Dreckschmidt, W. Zhong, T. D. Oberley, G. Wilding, and A. K. Verma. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer. Cancer Res. 67:8828–8838 (2007).
S. Shukla, G. T. Maclennan, S. R. Marengo, M. I. Resnick, and S. Gupta. Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model. Prostate. 64:224–239 (2005).
J. Suh, F. Payvandi, L. C. Edelstein, P. S. Amenta, W. X. Zong, C. Gélinas, and A. B. Rabson. Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells. Prostate. 52:183–200 (2002).
J. Suh and A. B. Rabson. NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon? J. Cell Biochem. 91:100–117 (2004).
B. B. Hafeez, S. Ahmed, N. Wang, S. Gupta, A. Zhang, and T. M. Haqqi. Green tea polyphenols-induced apoptosis in human osteosarcoma SAOS-2 cells involves a caspase-dependent mechanism with downregulation of nuclear factor-kappaB. Toxicol. Appl. Pharmacol. 216:11–19 (2006).
J. Bromberg. Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development. Breast Cancer Res. 2:86–90 (2000).
L. Pedranzini, A. Leitch, and J. Bromberg. Stat3 is required for the development of skin cancer. J. Clin. Invest. 114:619–622 (2004).
Acknowledgements
This original work for author’s laboratory was supported by US PHS Grants RO1 CA 78809; RO1 CA 101039, RO1 CA 120451 and O’Brian center Grant P50 DK065303-01.
Author information
Authors and Affiliations
Corresponding author
Additional information
Imtiaz A. Siddiqui and Yogeshwer Shukla contributed equally to this manuscript.
Rights and permissions
About this article
Cite this article
Siddiqui, I.A., Shukla, Y., Adhami, V.M. et al. Suppression of NFκB and its Regulated Gene Products by Oral Administration of Green Tea Polyphenols in an Autochthonous Mouse Prostate Cancer Model. Pharm Res 25, 2135–2142 (2008). https://doi.org/10.1007/s11095-008-9553-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-008-9553-z